Gossypol plus navitoclax COMBO in CLL ...early... - CLL Support

CLL Support

22,508 members38,657 posts

Gossypol plus navitoclax COMBO in CLL ...early study

Cllcanada profile image
CllcanadaTop Poster CURE Hero
2 Replies

The researchers found a very effective drug combination of gossypol plus navitoclax to kill CLL cells in the lab.

From the article...

Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) have found a combination of drugs to potentially treat chronic lymphocytic leukemia (CLL) more effectively. The research was published online on May 3, 2013, and it will appear as a letter in the journal Leukemia, a publication of the prestigious Nature Publishing Group. The study helps address a basic problem of treating CLL.

"Both drugs have been given to patients, but never in combination, because no one had the mechanistic rationale for doing that. Now we have what we think is the most promising drug combination so far for the treatment of CLL," says Eastman.

CLL cells in the lymph nodes have an increased level of a protein known as BCL-X. Gossypol likely inhibits this protein, which allows the navitoclax to work more effectively to kill the cancer cells. Eastman and his team tested this drug combination on CLL immediately after they came out on the patients.

The willingness of the patients to participate was integral to this study," Eastman adds. "After 40 years of research, I think this is the most promising idea I have had that might truly impact patient outcome."

The researchers hope a clinical trial will soon follow.

cancer.dartmouth.edu/about_...

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
jangreen profile image
jangreen

Hi Its good news that more drugs are coming on line it gives a hopeful future.

Cllcanada profile image
CllcanadaTop Poster CURE Hero

Both these drugs have been around about ten years, the news here is using them in combination. How they will work in humans is yet to be seen...

You may also like...

An Early Look at When CAR-T Therapy Fails Patients With CLL

cancertherapyadvisor.com/home/cancer-topics/chronic-lymphocytic-leukemia/chronic-leukemia-cll-early-

CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO

abstract studies second cancers in CLL patients on ibrutinib or acalabrutib....

Potential Early Drivers of Disease in Treatment-Naive CLL Identified

chronic lymphocytic leukemia (TN CLL) patients. The study findings were recently published in the...

New Dana Farber Research

The drug targets a protein STAT3 which triggers genes to cause the multiplication of CLL cancer...

Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLL

000 patients from three German CLL Study Group clinical trials has identified that unfit patients...